{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-309012","form_type":"8-K","ticker":"SGMO","cik":"0001001233","company_name":"SANGAMO THERAPEUTICS, INC","filed_at":"2026-07-20T20:44:31+00:00","discovered_at":"2026-07-20T20:45:00.535749+00:00","generated_at":"2026-07-20T20:45:20.673893+00:00","sec_items":["1.03","3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Sangamo Therapeutics receives Nasdaq delisting denial; bankruptcy court approves asset sale bidding procedures","bullets":["Bankruptcy court approved asset sale bidding procedures; bid deadline Aug 4, auction Aug 10, sale hearing Aug 20.","Nasdaq Hearings Panel denied listing continuation; company will not appeal; expects Form 25 delisting.","Stock suspended from Nasdaq since May 5, 2026; currently trades on OTCQB under symbol SGMOQ.","Company filed Chapter 11 on June 23, 2026; continues as debtor-in-possession under court jurisdiction."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-309012","json":"https://secwatch.observer/filing/0001193125-26-309012.json","markdown":"https://secwatch.observer/filing/0001193125-26-309012.md","text":"https://secwatch.observer/filing/0001193125-26-309012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001233/000119312526309012/0001193125-26-309012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001233/000119312526309012/d125683d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-20T20:45:20.673893+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}